AMPLATZER Duct Occluder II Clinical Study
NCT00713700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192
Last updated 2019-02-04
Summary
The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.
Conditions
- Patent Ductus Arteriosus
Interventions
- DEVICE
-
AMPLATZER Duct Occluder II
AMPLATZER Duct Occluder II
Sponsors & Collaborators
-
Abbott Medical Devices
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2011-10-31
- Completion
- 2016-10-05
Countries
- United States
Study Locations
More Related Trials
-
NIT-OCCLUD PDA Phase II Sentinel Trial
NCT00828334 ·Status: COMPLETED ·Phase: NA
-
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
NCT01314313 ·Status: COMPLETED ·Phase: NA
-
SIMPLAAFY Clinical Trial
NCT06521463 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection
NCT07170332 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access
NCT02088021 ·Status: WITHDRAWN ·Phase: NA
-
Canadian Left Atrial Appendage Closure Study
NCT03133806 ·Status: UNKNOWN ·Phase: NA
-
Evaluating the Use of the CapBuster System for the Crossing of CTO's in Coronary Arteries
NCT05733481 ·Status: UNKNOWN ·Phase: NA
-
Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon
NCT02812966 ·Status: TERMINATED ·Phase: NA
-
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT07276711 ·Status: RECRUITING ·Phase: NA
-
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study
NCT02949297 ·Status: COMPLETED ·Phase: NA
-
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
NCT00287508 ·Status: COMPLETED ·Phase: PHASE4
-
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts
NCT00283413 ·Status: COMPLETED ·Phase: NA
-
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
NCT02184442 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Thoracic Excluder Endoprosthesis to Treat Descending Thoracic Aortic Diseases
NCT00546312 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage
NCT00841529 ·Status: TERMINATED ·Phase: PHASE2
-
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
NCT07122518 ·Status: NOT_YET_RECRUITING
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NCT02818972 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Merit WRAPSODY Central Feasibility Study
NCT04541576 ·Status: WITHDRAWN ·Phase: NA
-
Disrupt CAD III Post-Approval Study (PAS)
NCT05021757 ·Status: COMPLETED
-
REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm
NCT01383720 ·Status: COMPLETED ·Phase: NA
-
PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO)
NCT01131793 ·Status: COMPLETED ·Phase: PHASE2
-
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NCT03970538 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)
NCT04059536 ·Status: WITHDRAWN
-
Zilver® PTX® V Clinical Study
NCT01901289 ·Status: COMPLETED ·Phase: NA
-
WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2
NCT03302494 ·Status: TERMINATED ·Phase: PHASE3